Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia
Ji Hyung Hong, Sung-Eun Lee, Soo Young Choi, Soo-Hyun Kim, Eun-Jung Jang, Ju-Hee Bang, Jin Eok Park, Hye-Rim Jeon, Yun Jeong Oh, Jeong-Eun Yi, Hae Ok Jung, Ho Joong Youn, Dong-Wook Kim
Cancer Res Treat. 2015;47(4):937-942. Published online 2014 Nov 17 DOI: https://doi.org/10.4143/crt.2013.155
Citations to this article as recorded by 
Prevalence and predictors of pulmonary hypertension in patients with myeloproliferative neoplasms: single-center study
Mohamed Eid, Ali M Kasem, Yasser M Kamal, Mahmoud Hamdy, Mahmoud Gaber
The Egyptian Journal of Haematology.2024; 49(1): 45. CrossRef
Relationship between Dasatinib-induced Pulmonary Hypertension and Drug Dose
Kana Kubota, Yasushi Imai, Iekuni Oh, Shuichi Ueno, Yoshinobu Kanda, Kazuomi Kario
Internal Medicine.2022; 61(15): 2263. CrossRef
Change of right ventricular systolic pressure can indicate dasatinib‐induced pulmonary arterial hypertension in chronic myeloid leukemia
Sung‐Eun Lee, Jee Hyun Kong, Soo‐Hyun Kim, Eun‐Jung Jang, Nack‐Gyun Chung, Bin Cho, Suk Joong Oh, Hae‐Eok Jung, Ho‐Joong Youn, Woo‐Baek Chung, Dong‐Wook Kim
Cancer Medicine.2021; 10(5): 1515. CrossRef
mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target
Aleksandra Babicheva, Ayako Makino, Jason X.-J. Yuan
International Journal of Molecular Sciences.2021; 22(4): 2144. CrossRef
Dasatinib-Induced Pulmonary Arterial Hypertension: A Case Report
Ru Liu, Yinjiang Tang, Ting Fu, Jianli Zhou, Lijiao Ma, Jinqing Yuan, Ou Xu
Research Reports in Clinical Cardiology.2021; Volume 12: 33. CrossRef
Pulmonary hypertension in patients with chronic myeloid leukemia
Ik-Chan Song, Sang-Hoon Yeon, Myeong-Won Lee, Hyewon Ryu, Hyo-Jin Lee, Hwan-Jung Yun, Byung Joo Sun, Jae-Hyeong Park, Jin-Ok Jeong, Deog-Yeon Jo
Medicine.2021; 100(33): e26975. CrossRef
A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities
Zahra Nekoukar, Minoo Moghimi, Ebrahim Salehifar
BLOOD RESEARCH.2021; 56(4): 229. CrossRef
Dasatinib-induced pulmonary arterial hypertension complicated with scleroderma: a case report
Takumi Toya, Yuji Nagatomo, Kazuki Kagami, Takeshi Adachi, Julia Grapsa, Julia Grapsa, Hatem Soliman Aboumarie, Amir Aziz, Peysh A Patel
European Heart Journal - Case Reports.2019;[Epub] CrossRef
Dasatinib‐induced pulmonary arterial hypertension
Nurgül Özgür Yurttaş, Ahmet Emre Eşkazan
British Journal of Clinical Pharmacology.2018; 84(5): 835. CrossRef
Comparative analysis of pulmonary hypertension in patients treated with imatinib, nilotinib and dasatinib
Mariko Minami, Takeshi Arita, Hiromi Iwasaki, Tsuyoshi Muta, Takatoshi Aoki, Kenichi Aoki, Satoshi Yamasaki, Takamitsu Matsushima, Koji Kato, Katsuto Takenaka, Kazuki Tanimoto, Tomohiko Kamimura, Ryosuke Ogawa, Koichi Akashi, Toshihiro Miyamoto
British Journal of Haematology.2017; 177(4): 578. CrossRef
Combination targeted pulmonary hypertension therapy in the resolution of Dasatinib‐associated pulmonary arterial hypertension
Arun Jose, Hind Rafei, Jalil Ahari
Pulmonary Circulation.2017; 7(4): 803. CrossRef
Pulmonary arterial hypertension in a patient treated with dasatinib: a case report
Andris Skride, Matiss Sablinskis, Kristaps Sablinskis, Krista Lesina, Aivars Lejnieks, Sandra Lejniece
Journal of Medical Case Reports.2017;[Epub] CrossRef
Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease
Diederik E. van der Feen, B. Bartelds, Rudolf A. de Boer, Rolf M.F. Berger
European Heart Journal.2017; 38(26): 2034. CrossRef
Dasatinib
Reactions Weekly.2015; 1580(1): 136. CrossRef
Deletion of Src family kinase Lyn aggravates endotoxin-induced lung inflammation
Rong Gao, Zhongsen Ma, Mengshi Ma, Jinyan Yu, Jiao Chen, Zhenyu Li, Sreerama Shetty, Jian Fu
American Journal of Physiology-Lung Cellular and Molecular Physiology.2015; 309(11): L1376. CrossRef